Ribavirin for the treatment of Lassa fever: A systematic review and meta-analysis
Objectives: Lassa fever (LF) causes annual outbreaks in endemic regions with high mortality of symptomatic patients. Ribavirin is recommended as standard treatment for LF in national and international guidelines but the evidence base for this recommendation has been questioned recently. Methods: We...
Main Authors: | Kirsten Alexandra Eberhardt, Johannes Mischlinger, Sabine Jordan, Mirjam Groger, Stephan Günther, Michael Ramharter |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-10-01
|
Series: | International Journal of Infectious Diseases |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1201971219303005 |
Similar Items
-
Ribavirin for Lassa Fever Postexposure Prophylaxis
by: Christiane M. Hadi, et al.
Published: (2010-12-01) -
Time to reconsider the role of ribavirin in Lassa fever.
by: Alex Paddy Salam, et al.
Published: (2021-07-01) -
Laboratory Diagnosis of Lassa Fever, Liberia
by: Marcus Panning, et al.
Published: (2010-06-01) -
Lassa Fever, Nigeria, 2005–2008
by: Deborah U. Ehichioya, et al.
Published: (2010-06-01) -
Lassa Fever, Nigeria, 2003 and 2004
by: Sunday Aremu Omilabu, et al.
Published: (2005-10-01)